Anika Therapeutics, Inc. Public Float
Anika Therapeutics, Inc. (ANIK) had Public Float of $147.34 million as of 2025-06-30, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-03
- 2025-06-30: Entity Public Float $147.34M.
- 2024-06-30: Entity Public Float $373.15M.
- 2023-06-30: Entity Public Float $370.43M.
- 2022-06-30: Entity Public Float $321.81M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $147.34M 10-K · filed 2026-03-03 |
| 2024-06-30 | $373.15M 10-K · filed 2025-03-17 |
| 2023-06-30 | $370.43M 10-K/A · filed 2024-04-26 |
| 2022-06-30 | $321.81M 10-K · filed 2023-03-16 |
| 2021-06-30 | $619.54M 10-K · filed 2022-03-11 |
| 2020-06-30 | $530.77M 10-K/A · filed 2021-04-26 |
| 2019-06-30 | $570.29M 10-K · filed 2020-03-06 |
| 2018-06-30 | $460.21M 10-K · filed 2019-02-27 |
| 2017-06-30 | $702.11M 10-K · filed 2018-02-27 |
| 2016-06-30 | $769.98M 10-K · filed 2017-02-24 |
| 2015-06-30 | $483.20M 10-K · filed 2016-03-10 |
| 2014-06-30 | $682.06M 10-K · filed 2015-03-13 |
| 2013-06-30 | $228.89M 10-K · filed 2014-03-13 |
| 2012-06-30 | $187.08M 10-K · filed 2013-03-14 |
| 2011-06-30 | $96.99M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |